In Brief: FoxMeyer
FoxMeyer: Unsecured creditors of wholesaler file $198 mil. suit against FoxMeyer Health on Nov. 25. The suit seeks damages for allegedly fraudulent transfer of assets from FoxMeyer Drug and FoxMeyer Corp. to FoxMeyer Health as a result of restructuring in June two months before distribution business filed for Chapter 11 protection...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth